U.S. Sexual Dysfunction Medication Markets

U.S. Sexual Dysfunction Medication Markets

 

RELEASE DATE
12-Sep-2003
REGION
North America
Research Code: A531-01-00-00-00
SKU: HC00906-NA-MR_04697
AvailableYesPDF Download

$2,450.00

Special Price $1,837.50 save 25 %

In stock
SKU
HC00906-NA-MR_04697

$2,450.00

$1,837.50save 25 %

DownloadLink
ENQUIRE NOW

Description

The U.S. Sexual Dysfunction Medication markets report provides revenue forecasts, patient forecasts, pricing forecasts, competitive analysis, market trends, and product analysis. The market is segmented into the male sexual dysfunction medication market and the female sexual dysfunction medication market. Within the male segment, subsegments analyzed in detail include the erectile dysfunction and hypogonadism medication markets addressing the various medication classes used to treat these conditions. Within the female segment, subsegments analyzed in detail include the hypoactive desire disorder and female sexual arousal disorder markets addressing the various medication classes used in treating these conditions.

Table of Contents

Overview

  • Introduction
  • Report Scope and Segmentation
  • Customer Segmentation and Targeting Strategies

Market Dynamics

  • Market Drivers (Male and Female Market Segments)
  • Market Restraints (Male and female market segments)
  • Challenge 1: Low Medication Compliance Limits Revenue Potential
  • Challenge 2: Restricted Product Differentiation Intensifies Competition and Diminishes Revenue Potential
  • Challenge 3: Growing Difficulty in Securing Reimbursement Curbs Revenue Growth

Market Forecasts and Trends

  • Demand Analysis (Males and Females)
  • Market Trends
  • Revenue Forecast

Competitive Analysis

  • Competitive Structure and Strategic Relationships
  • Auxilium Pharmaceuticals
  • Cellegy Pharmaceuticals
  • Eli Lilly/ICOS
  • BioSante Pharmaceuticals
  • MacroChem Corporation
  • NexMed Inc.
  • Product Life Cycle Analysis

Product Analysis

  • Approved Products and Patent and Market Exclusivity Expirations
  • Frost & Sullivan Technology Innovation Award
  • Product Pipeline for the Total Sexual Dysfunction Market
Related Research
The U.S. Sexual Dysfunction Medication markets report provides revenue forecasts, patient forecasts, pricing forecasts, competitive analysis, market trends, and product analysis. The market is segmented into the male sexual dysfunction medication market and the female sexual dysfunction medication market. Within the male segment, subsegments analyzed in detail include the erectile dysfunction and hypogonadism medication markets addressing the various medication classes used to treat these conditions. Within the female segment, subsegments analyzed in detail include the hypoactive desire disorder and female sexual arousal disorder markets addressing the various medication classes used in treating these conditions.
More Information
No Index Yes
Podcast No
Industries Healthcare
WIP Number A531-01-00-00-00
Is Prebook No